8-K - Genprex, Inc. | StockGist

Current Report Details

Event Type

Regulation Fd

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

7.01

, including the information contained in Exhibit 99.1, is being furnished to the Securities and Exchange Commission, and shall not be deemed to be “filed” for t

Regulation Fd

8.01

Other Events. On January 7, 2026, Genprex issued a press release announcing clinical program updates on its diabetes gene therapy program for GPX-002, the Compa

Other Event

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Investor Presentation. 104 Cover Page Interactive Data File (embedded within th

Exhibits Only

Source Document

Exhibits (2)

8-K

FORM 8-K

99.1

EXHIBIT 99.1